We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Hand-Held Hemoglobin Analyzer with Secure POC Connectivity Enables Hematocrit Calculation

By LabMedica International staff writers
Posted on 19 Oct 2022

DiaSpect Tm, the hand-held hemoglobin analyzer from EKF Diagnostics (Penarth, Cardiff, UK), now connects securely to EKF Link, the company’s own point-of-care (POC) middleware, enabling additional features including a calculated hematocrit value and data management.

The DiaSpect Tm is a palm-sized, lightweight, robust and easily transportable POC hemoglobin analyzer that can be used in any screening setting, even in challenging climatic environments. This is because its reagent-less microcuvettes have up to 2.5 years shelf life, even after opening, and are unaffected by temperature and humidity. Its ‘always-on’ technology enables professionals to start using the device immediately; and the rechargeable internal battery, which provides up to 40 days/10,000 tests continuous use, offers the flexibility of not needing a power source for weeks at a time. The enhanced DiaSpect Tm can now be connected to the recently released EKF Link middleware, ensuring that test results are stored and accessed securely on a centralized platform. EKF’s DiaSpect Tm is also now equipped with Bluetooth, internal storage for 4000 tests and QC results, as well as the capability to provide a calculated hematocrit value alongside the usual hemoglobin result.


Image: DiaSpect Tm POC hemoglobin analyzer is now powered by EKF Link digital connectivity solution (Photo courtesy of EKF Diagnostics)
Image: DiaSpect Tm POC hemoglobin analyzer is now powered by EKF Link digital connectivity solution (Photo courtesy of EKF Diagnostics)

Moving into a new era of POC connectivity, the DiaSpect Tm results are easily accessible from a web browser through EKF Link while being securely protected on the servers already available in most laboratories and hospitals. Patient and operator identification allow for better tracking of both staff competence and test results, and a Quality Control reminder function ensures compliance with ever tightening local regulations. Enabling rapid decision making, the DiaSpect Tm simultaneously delivers hemoglobin with calculated hematocrit results in under two seconds from just 10 µL of capillary or venous blood collected in microcuvettes and inserted directly into the analyzer. This makes it extremely user-friendly requiring minimal training. In addition, no calibration is required as it is factory calibrated against the HiCN reference method, and turbidity is also measured and compensated for. Available globally, the DiaSpect Tm has received an IVD CE-mark, FDA clearance and is registered in many more countries across all continents.

“Our new DiaSpect Tm will enable POC coordinators, operating rooms and screening programs to connect this fast and reliable photometric hemoglobin analyzer to Laboratory Information Systems (LIS) or Patient Information Systems (PIS) through EKF Link,” said David Wojahn, Hematology Product Manager for EKF Diagnostics. “Now with the EKF Link connectivity, DiaSpect Tm is an ideal POC solution enabling users to rapidly upload results from anywhere and power up their performance, delivering results directly alongside the patient or blood donor.”

Related Links:
EKF Diagnostics 


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Entamoeba One Step Card Test
CerTest Entamoeba
New
Chemistry Analyzer
MS100

Latest Hematology News

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients